← Back to Search

Imaging Device

SECM Skin Imaging for Skin Diseases

N/A

Waitlist Available

Led By Guillermo Tearney, M.D, PhD.

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Capable of giving informed consent

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up imaging data is collected during the procedure, and analyzed within 1 year of collection.

Awards & highlights

Study Summary

This trial will test how well SECM can image human skin and skin diseases.

Who is the study for?

This trial is for healthy adults over 18 who can give informed consent and have pigmented skin lesions, like moles, on their forearm. It's not open to those unable to consent, with open cuts/sores or infections on the skin, pregnant women, or employees supervised by the investigator.Check my eligibility

What is being tested?

The study is testing a new way of looking at human skin using Spectrally Encoded Confocal Microscopy (SECM). The goal is to see how well SECM can image the skin and identify any diseases present in it.See study design

What are the potential side effects?

Since this trial involves imaging technology rather than medication or invasive procedures, significant side effects are not expected. However, there may be minimal risks associated with exposure to light or minor discomfort from the imaging device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I understand the study and can agree to participate.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ imaging data is collected during the procedure, and analyzed within 1 year of collection.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~imaging data is collected during the procedure, and analyzed within 1 year of collection.

This trial's timeline: 3 weeks for screening, Varies for treatment, and imaging data is collected during the procedure, and analyzed within 1 year of collection. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Ability of SECM device to image skin and skin diseases

Trial Design

1Treatment groups

Experimental Treatment

Group I: SECM Skin ImagingExperimental Treatment1 Intervention

The SECM skin imaging procedure will be very similar to that by the FDA approved RCM devices. First, the skin lesion (such as a mole) will be identified on a forearm of the subject. The lesion will be imaged first with a dermatoscope, and then with the SECM device. A dermatoscope is a hand-held device used for the visual observation of the epidermis. It is a superior surface contact microscope used to examine skin lesions.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,345 Total Patients Enrolled

Guillermo Tearney, M.D, PhD.Principal InvestigatorMassachusetts General Hospital

6 Previous Clinical Trials

630 Total Patients Enrolled

Media Library

SECM Skin Imaging (Imaging Device) Clinical Trial Eligibility Overview. Trial Name: NCT04566302 — N/A

Mole Research Study Groups: SECM Skin Imaging

Mole Clinical Trial 2023: SECM Skin Imaging Highlights & Side Effects. Trial Name: NCT04566302 — N/A

SECM Skin Imaging (Imaging Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04566302 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there available vacancies in this research project for participants?

"The clinical trial's page hosted on clinicaltrials.gov indicates that recruitment is no longer occurring as of July 21st 2021, although the post was first made 2 days earlier. Fortunately, 16 other medical trials are actively looking for participants at this present juncture."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy

Guillermo Tearney 2021. "Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04566302.